Teng Wei Chen

Director/Board Member en AIMFINITY INVESTMENT CORP. I .

55 años

Finance

Consumer Services

Perfil

Teng Wei Chen is an Independent Director at Aimfinity Investment Corp.
I and Inkstone Feibo Acquisition Corp.
He is also a Director at New-Shine Biomedical Co., Ltd.
Dr. Chen holds a doctorate degree from China Medical University (Taiwan).

Cargos activos de Teng Wei Chen

Empresas	Cargo	Inicio
AIMFINITY INVESTMENT CORP. I	Director/Board Member	17/03/2023
Inkstone Feibo Acquisition Corp. Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE.	Director/Board Member	-
New-Shine Biomedical Co., Ltd.	Director/Board Member	01/01/2018

Todos los cargos activos de Teng Wei Chen

Formación de Teng Wei Chen.

China Medical University (Taiwan)

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Teng Wei Chen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
AIMFINITY INVESTMENT CORP. I	Finance

Empresas privadas	2
Inkstone Feibo Acquisition Corp. Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE.	Finance
New-Shine Biomedical Co., Ltd.